USPTO serial 99749361
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 10, 2026
The examiner issued refusals due to likelihood of confusion with an existing mark, an unacceptable specimen, and a required disclaimer for descriptive wording.
Functional Longevity Labs, Inc.
Easton, MD, US
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Therapeutic pharmaceutical for the treatment of neurodegeneration; Nutraceuticals for use as a dietary supplement | ACTIVE | Apr 7, 2026 |
| Date | Code | Event |
|---|---|---|
| Aug 10, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 10, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jun 29, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 7, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Apr 7, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 7, 2026 | NWAP | NEW APPLICATION ENTERED |